Bayer CropScience is currently trading at Rs 1718.00, up by 61.45 points or 3.71% from its previous closing of Rs 1656.55 on the BSE.
The scrip opened at Rs 1707.00 and has touched a high and low of Rs 1769.00 and Rs 1705.10 respectively. So far 14321 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 1769.00 on 18-Jul-2013 and a 52 week low of Rs 765.05 on 25-Jul-2012.
Last one week high and low of the scrip stood at Rs 1769.00 and Rs 1514.00 respectively. The current market cap of the company is Rs 6831.11 crore.
The promoters holding in the company stood at 71.11% while Institutions and Non-Institutions held 16.83% and 12.07% respectively.
Bayer Cropscience, the agrochemicals manufacturer is planning to buyback its own shares from the public shareholders. In this regard, the company’s board will meet on July 22, 2013 to consider on the same. At present, the promoter Bayer AG and others hold 71.11% stake in its Indian arm.
Domestic institutional investors held 11.56% stake followed by individual shareholders (8.52%), foreign institutional investors (5.27%) and bodies corporate (3.52%). Bayer CropScience is one of the world's leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control.
| Company Name | CMP |
|---|---|
| UPL | 658.70 |
| PI Industries | 3055.85 |
| Bayer CropScience | 4845.65 |
| Sharda Cropchem | 1111.30 |
| Sumitomo Chemical | 443.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: